Medpace Holdings logo
Medpace Holdings MEDP
$ 531.0 -0.16%

Quarterly report 2025-Q2
added 07-22-2025

report update icon

Medpace Holdings Gross Profit 2011-2025 | MEDP

Gross profit is a key indicator of how efficiently a company produces or sells its products. This metric helps assess a business’s ability to generate revenue at the initial stage, before accounting for all other expenses. Regular analysis of gross profit allows companies to respond in a timely manner to changes in cost of goods, pricing strategy, and market conditions.

Calculation formula:
Gross Profit = Revenue – Cost of Goods Sold (COGS)

Revenue — all cash inflows from the sale of goods or services.
Cost of Goods Sold — direct costs related to the production or acquisition of goods:
  • Raw materials and supplies
  • Wages of production personnel
  • Depreciation of equipment
  • Transportation and warehousing costs (if directly related to production)
Importance for business:
  • Assessing core business profitability
    If gross profit is declining, it may indicate rising production costs or falling sales.
  • Financial planning
    Gross profit is the basis for calculating other key metrics, such as operating and net profit.
  • Benchmarking against competitors
    Gross profit analysis helps compare the efficiency of different companies within the same industry.
  • Insights into pricing effectiveness
    If gross profit is low, the company may be pricing too low or failing to control costs effectively.
Reasons for a decline in gross profit:
  • Increase in raw material and supply costs
  • Rising production expenses
  • Price reductions due to competition
  • Decrease in sales volume
  • Currency exchange rate fluctuations (for imports/exports)

Gross profit is an important metric, but it does not provide a complete picture of a company’s financial health, as it does not account for administrative and selling expenses, taxes, debt burden, or depreciation.

Annual Gross Profit Medpace Holdings

2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
- - - - - 246 M 216 M 175 M 172 M 156 M - 124 M - -
2024202420232023202220222021202120202020201920192018201820172017201620162015201520142014201320132012201220112011300 M300 M240 M240 M180 M180 M120 M120 M60 M60 M00
Download SVG
Download PNG
Download CSV

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
246 M 124 M 181 M

Gross Profit of other stocks in the Diagnostics research industry

Issuer Gross Profit Price % 24h Market Cap Country
Danaher Corporation Danaher Corporation
DHR
14.2 B $ 204.96 -1.82 % $ 150 B usaUSA
Centogene N.V. Centogene N.V.
CNTG
17.2 M $ 0.33 -6.23 % $ 30.6 M germanyGermany
Fluidigm Corporation Fluidigm Corporation
FLDM
83.3 M $ 3.75 1.08 % $ 308 M usaUSA
Global Cord Blood Corporation Global Cord Blood Corporation
CO
1.06 B $ 2.99 - $ 399 M chinaChina
Oxford Immunotec Global PLC Oxford Immunotec Global PLC
OXFD
54.4 M $ 21.99 - $ 562 M britainBritain
Genetron Holdings Limited Genetron Holdings Limited
GTH
281 M $ 4.03 0.12 % $ 80.1 M chinaChina
Lantheus Holdings Lantheus Holdings
LNTH
988 M $ 53.55 3.3 % $ 3.71 B usaUSA
Chembio Diagnostics Chembio Diagnostics
CEMI
6.58 M $ 0.46 0.22 % $ 16.8 M usaUSA
Meridian Bioscience Meridian Bioscience
VIVO
188 M $ 33.97 - $ 1.49 B usaUSA
HTG Molecular Diagnostics HTG Molecular Diagnostics
HTGM
4.56 M $ 0.48 -20.0 % $ 1.06 M usaUSA
Neogen Corporation Neogen Corporation
NEOG
421 M $ 5.82 4.11 % $ 1.26 B usaUSA
Quotient Limited Quotient Limited
QTNT
23.3 M $ 0.32 -11.32 % $ 1.1 M schweizSchweiz
Pacific Biosciences of California Pacific Biosciences of California
PACB
52.8 M $ 1.51 7.86 % $ 383 M usaUSA
Bioventus Bioventus
BVS
328 M $ 6.76 1.65 % $ 423 M usaUSA
PRA Health Sciences, Inc. PRA Health Sciences, Inc.
PRAH
869 M $ 165.21 - $ 10.7 B usaUSA
Heska Corporation Heska Corporation
HSKA
111 M $ 119.99 - $ 1.31 B usaUSA
Trinity Biotech plc Trinity Biotech plc
TRIB
21.4 M $ 1.06 -0.47 % $ 61.9 M irlandaIrlanda
Twist Bioscience Corporation Twist Bioscience Corporation
TWST
6.96 M $ 32.79 5.37 % $ 1.9 B usaUSA
Motus GI Holdings Motus GI Holdings
MOTS
-398 K $ 0.17 -34.28 % $ 263 K israelIsrael
Biocept Biocept
BIOC
6.12 M $ 0.43 -13.05 % $ 7.29 M usaUSA
Syneos Health Syneos Health
SYNH
4.42 B $ 42.98 - $ 4.46 B usaUSA
Invitae Corporation Invitae Corporation
NVTA
98.7 M $ 0.09 - $ 21.2 M usaUSA
DermTech DermTech
DMTK
276 K $ 0.09 -11.32 % $ 2.94 M usaUSA
Akumin Akumin
AKU
53.5 M $ 0.29 -17.87 % $ 25.9 M canadaCanada
Castle Biosciences Castle Biosciences
CSTL
53 M $ 23.59 2.92 % $ 655 M usaUSA
DarioHealth Corp. DarioHealth Corp.
DRIO
5.98 M $ 16.37 5.27 % $ 464 M israelIsrael
Brainsway Ltd. Brainsway Ltd.
BWAY
30.6 M $ 15.53 1.94 % $ 99.4 M israelIsrael
PerkinElmer PerkinElmer
PKI
523 M $ 115.24 -0.91 % $ 14.7 B usaUSA
OpGen OpGen
OPGN
366 K $ 1.96 -16.95 % $ 1.54 M usaUSA
Guardant Health Guardant Health
GH
144 M $ 65.32 2.96 % $ 8.02 B usaUSA
DexCom DexCom
DXCM
2.29 B $ 67.78 2.65 % $ 26.2 B usaUSA
Organovo Holdings Organovo Holdings
ONVO
1.87 M $ 2.12 -2.3 % $ 19.4 M usaUSA
Burning Rock Biotech Limited Burning Rock Biotech Limited
BNR
364 M $ 8.82 -2.17 % $ 94.9 M chinaChina
Biomerica Biomerica
BMRA
498 K $ 2.88 1.41 % $ 6.62 M usaUSA
Fulgent Genetics Fulgent Genetics
FLGT
107 M $ 22.83 0.88 % $ 690 M usaUSA
Psychemedics Corporation Psychemedics Corporation
PMD
8.41 M $ 2.67 -1.84 % $ 15.3 M usaUSA
Genetic Technologies Limited Genetic Technologies Limited
GENE
-251 K $ 0.77 - $ 7.1 B australiaAustralia
Myriad Genetics Myriad Genetics
MYGN
585 M $ 7.64 1.46 % $ 692 M usaUSA
Renalytix AI plc Renalytix AI plc
RNLX
156 K $ 0.21 5.66 % $ 22.7 M britainBritain
CareDx, Inc CareDx, Inc
CDNA
81.6 M $ 14.79 0.82 % $ 795 M usaUSA
IQVIA Holdings IQVIA Holdings
IQV
3.79 B $ 200.6 -0.13 % $ 36.4 B usaUSA
Koninklijke Philips N.V. Koninklijke Philips N.V.
PHG
7.77 B $ 28.25 1.51 % $ 20 B niderlandNiderland
Biodesix Biodesix
BDSX
18.5 M $ 7.75 6.16 % $ 1 B usaUSA
T2 Biosystems T2 Biosystems
TTOO
-3.15 M $ 0.12 -39.35 % $ 313 K usaUSA
Quidel Corporation Quidel Corporation
QDEL
1.35 B $ 27.86 0.56 % $ 1.17 B usaUSA
Agilent Technologies Agilent Technologies
A
2.84 B $ 140.81 1.62 % $ 42.8 B usaUSA
Co-Diagnostics Co-Diagnostics
CODX
2.63 M $ 0.39 5.12 % $ 11.4 M usaUSA